GlassScriptPhysician profile
Matthew Bobel
NPI 1851788046
$6,405.17
in general payments reported to CMS, 2019-2025
6 companies · $4,157 in 2025
The $4,157 reported for 2025 was more than what 87% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.94 · 2023: $1,936 · 2024: $299 · 2025: $4,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,718 · Travel and Lodging: $2,523 · Food and Beverage: $852 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,717.50 |
| Travel and Lodging | $2,523.21 |
| Food and Beverage | $851.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,670.03 | 2020-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $644.38 | 2023 | Interstim |
| Innovation Technologies INC | $35.73 | 2025 | Irrisept |
| Integra Lifesciences Corporation | $21.34 | 2024 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $19.27 | 2024 | Harmonic, Stratafix, Echelon; Endopath |
| Distalmotion US | $14.42 | 2025 | Dexter L6 Robot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.